Systemic increase of AMPA receptors associated with cognitive impairment of long COVID
Long COVID primarily presents with persistent cognitive impairment (Cog-LC), imposing a substantial and lasting global burden. Even after the pandemic, there remains a critical global need for diagnostic and...
Moved post
FWIW, some patients have experienced reduced brain with Fycompa
Low dose fycompa (2mg) was a game changer for me for reducing „brainfog“ and migraines.
Slow reveal—the paper will be in German apparently—putting this here as place holder until they reveal the treatment in the next few days. I’m always skeptical of these slow reveal deals—might be scam-ish??
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.